Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
8
×
detroit blog main
detroit top stories
fda
8
×
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
8
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
life sciences
clinical trials
eli lilly
merck
abbvie
cancer
pfizer
regeneron pharmaceuticals
startups
amgen
astrazeneca
biogen
What
bio
roundup
8
×
industry
nash
pharmaceutical
policy
american
based
best
biotech
continue
crash
days
debate
drug
drugs
fda
growing
healthcare
kind
news
people
politicians
pressure
scalps
trump’s
u.s
alliance
alzheimer’s
annual
appetite
approved
assessed
attention
august
biopharma
black
bread
bristol
busy
Language
unset
Current search:
fda
×
roundup
×
" bristol-myers squibb "
×
" new york top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More